Literature DB >> 28258055

Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia.

Ridhima Lal1, Karin Lind1, Ellen Heitzer2, Peter Ulz2, Kristina Aubell2, Karl Kashofer3, Jan M Middeke4, Christian Thiede4, Eduard Schulz1, Angelika Rosenberger1, Sybille Hofer1, Birgit Feilhauer1, Beate Rinner5, Vendula Svendova6, Michael G Schimek6, Frank G Rücker7, Gerald Hoefler3, Konstanze Döhner7, Armin Zebisch1, Albert Wölfler1, Heinz Sill1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28258055     DOI： 10.1182/blood-2016-11-751008

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  20 in total

1.  STAT3β is a tumor suppressor in acute myeloid leukemia.

Authors:  Petra Aigner; Tatsuaki Mizutani; Jaqueline Horvath; Thomas Eder; Stefan Heber; Karin Lind; Valentin Just; Herwig P Moll; Assa Yeroslaviz; Michael J M Fischer; Lukas Kenner; Balázs Győrffy; Heinz Sill; Florian Grebien; Richard Moriggl; Emilio Casanova; Dagmar Stoiber
Journal:  Blood Adv       Date:  2019-07-09

2.  The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.

Authors:  Doriana Gramegna; Diego Bertoli; Chiara Cattaneo; Camillo Almici; Alessandro Re; Angelo Belotti; Erika Borlenghi; Gaetana Lanzi; Silvana Archetti; Rosanna Verardi; Duilio Brugnoni; Margherita Sciumè; Rosa Daffini; Aldo M Roccaro; Alessandra Tucci; Giuseppe Rossi
Journal:  Ann Hematol       Date:  2022-04-05       Impact factor: 3.673

Review 3.  Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-09-01       Impact factor: 3.122

4.  Acute Myeloid Leukemia and Myelodysplastic Syndromes with TP53 Aberrations - A Distinct Stem Cell Disorder.

Authors:  Heinz Sill; Armin Zebisch; Detlef Haase
Journal:  Clin Cancer Res       Date:  2020-08-14       Impact factor: 12.531

5.  Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.

Authors:  Yin Li; Yan Wang; Yong Zhou; Jie Li; Kai Chen; Leisi Zhang; Manman Deng; Suqi Deng; Peng Li; Bing Xu
Journal:  Clin Epigenetics       Date:  2017-08-14       Impact factor: 6.551

Review 6.  Evolutionary trajectory of leukemic clones and its clinical implications.

Authors:  Amos Tuval; Liran I Shlush
Journal:  Haematologica       Date:  2019-04-19       Impact factor: 9.941

7.  TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model.

Authors:  Gabriel Pabst; Karin Lind; Ricarda Graf; Armin Zebisch; Friedrich Stölzel; Konstanze Döhner; Ellen Heitzer; Andreas Reinisch; Heinz Sill
Journal:  Ann Hematol       Date:  2020-01-30       Impact factor: 3.673

Review 8.  Chromosomal Instability in Acute Myeloid Leukemia.

Authors:  Mateus de Oliveira Lisboa; Paulo Roberto Slud Brofman; Ana Teresa Schmid-Braz; Aline Rangel-Pozzo; Sabine Mai
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

9.  Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential.

Authors:  Terrence N Wong; Christopher A Miller; Matthew R M Jotte; Nusayba Bagegni; Jack D Baty; Amy P Schmidt; Amanda F Cashen; Eric J Duncavage; Nichole M Helton; Mark Fiala; Robert S Fulton; Sharon E Heath; Megan Janke; Kierstin Luber; Peter Westervelt; Ravi Vij; John F DiPersio; John S Welch; Timothy A Graubert; Matthew J Walter; Timothy J Ley; Daniel C Link
Journal:  Nat Commun       Date:  2018-01-31       Impact factor: 14.919

10.  Clinical implications of subclonal TP53 mutations in acute myeloid leukemia.

Authors:  Katharina T Prochazka; Gudrun Pregartner; Frank G Rücker; Ellen Heitzer; Gabriel Pabst; Albert Wölfler; Armin Zebisch; Andrea Berghold; Konstanze Döhner; Heinz Sill
Journal:  Haematologica       Date:  2018-10-11       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.